Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Diabetes Reports
Published in: Current Diabetes Reports 5/2022

01-05-2022 | Lifestyle Modifications | Psychosocial Aspects (J Pierce, Section Editor)

Applying Behavioral Economics Theories to Interventions for Persons with Diabetes

Authors: Susana R. Patton, Christopher C. Cushing, Amy Hughes Lansing

Published in: Current Diabetes Reports | Issue 5/2022

Login to get access

Abstract

Purpose of Review

To introduce behavioral economics (BE), provide a description of how recent prevention and treatment interventions in persons with diabetes have incorporated BE in their intervention strategies, and discuss how BE could be used to inform new treatments for the clinical setting or research.

Recent Findings

In most of the trials described, researchers incorporated BE into their design in the form of incentives, which can align with present bias, optimism bias, and loss aversion. With only two exceptions, these trials reported preliminary support for using incentives to promote lifestyle modifications and diabetes-related tasks. Additionally, two trials reported promising results for behavior change strategies informed by default bias, while three trials reported promising results for behavior change strategies informed by social norms.

Summary

Recent trials incorporating BE in prevention and treatment interventions for persons with diabetes generally report promising results, though gaps exist for research and clinical deployment.
Literature
1.
American Diabetes Association 13. Children and adolescents: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S163–S82.
2.
Diabetes Control and Complications Trial /Epidemiology of Diabetes I, Complications Research G, Lachin JM, White NH, Hainsworth DP, et al. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 2015;64(2):631–42.CrossRef
3.
Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66–72.PubMedPubMedCentralCrossRef
4.
Diabetes Prevention Program Research G, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677–86.CrossRef
5.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.PubMedCrossRef
6.
American Diabetes Association 3. Prevention or delay of type 2 diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S34–S9.CrossRef
7.
American Diabetes Association 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S100–S10.CrossRef
8.
Hood KK, Rohan JM, Peterson CM, Drotar D. Interventions with adherence-promoting components in pediatric type 1 diabetes: meta-analysis of their impact on glycemic control. Diabetes Care. 2010;33(7):1658–64.PubMedPubMedCentralCrossRef
9.
Pimouguet C, Le Goff M, Thiebaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ. 2011;183(2):E115–27.PubMedPubMedCentralCrossRef
10.
Winkley K, Upsher R, Stahl D, Pollard D, Brennan A, Heller S, et al. Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in children and adults with type 1 diabetes. Diabet Med. 2020;37(5):735–46.PubMedPubMedCentralCrossRef
11.
12.
Cartwright E. Behavioral Economics. Florence: Routledge; 2011.
13.
Ariely D. Predictably irrational: hidden forces that shape our decisions. New York: Harper Collins Publishers; 2008.
14.
Rice T. The behavioral economics of health and health care. Annu Rev Public Health. 2013;34:431–47.PubMedCrossRef
15.
O’Donoghue R, Rabin M. Doing it now or later. Am Econ Rev. 1999;89(1):103–24.CrossRef
16.
Loewenstein G, John L, Volpp KG. Using decision errors to help people help themselves. In: Shafir E, editor. The behavioral foundations of public policy. Princeton: Princeton University Press; 2013. p. 361–79.CrossRef
17.
Luoto J, Carman KG. Behavioral economics guidelines with applications for health interventions. Washington DC: Inter-American Development Bank; 2014.
18.
Tversky A, Kahneman D. Loss aversion in the riskless choice: a reference-dependent model. Q J Econ. 1991;106:1039–61.CrossRef
19.
Samuelson W, Zeckhauser R. Status quo bias in decision making. J Risk Uncertain. 1988;1(1):7–59.CrossRef
20.
Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2415–7.PubMedCrossRef
21.
Cialdini RB. Crafting normative messages to protect the environment. Curr Dir Psychol Sci. 2003;12:105–10.CrossRef
22.
Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth, and happiness. New Haven: Yale University Press; 2008.
23.
Stevens J. Behavioral economics as a promising framework for promoting treatment adherence to pediatric regimens. J Pediatr Psychol. 2014;39(10):1097–103.PubMedCrossRef
24.
Hoskins K, Ulrich CM, Shinnick J, Buttenheim AM. Acceptability of financial incentives for health-related behavior change: an updated systematic review. Prev Med. 2019;126:105762.PubMedCrossRef
25.
Miranda JJ, Lazo-Porras M, Bernabe-Ortiz A, Pesantes MA, Diez-Canseco F, Cornejo SDP, et al. The effect of individual and mixed rewards on diabetes management: a feasibility randomized controlled trial. Wellcome Open Res. 2018;3:139.PubMedCrossRef
26.
• Judah G, Darzi A, Vlaev I, Gunn L, King D, King D, et al. Financial disincentives? A three-armed randomised controlled trial of the effect of financial Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial. Br J Ophthalmol. 2018;102(8):1014–20 This randomized controlled trial tested the efficacy of using financial incentives to promote completion of annual retinopathy screening visits and instead found that they led to lower screening visit completion rates among participants.PubMedCrossRef
27.
• Chin JY, Matson J, McCauley S, Anarella J, Gesten F, Roohan P. The impact of financial incentives on utilization and outcomes of diabetes prevention programs among Medicaid managed care adults in New York state. Contemp Clin Trials. 2020;91:105960. This randomized controlled trial found efficacy for using financial incentives to promote enrollment in and completion of a Diabetes Prevention Program in adults with prediabetes and/or obesity.
28.
Raiff BR, Jarvis BP, Dallery J. Text-message reminders plus incentives increase adherence to antidiabetic medication in adults with type 2 diabetes. J Appl Behav Anal. 2016;49(4):947–53.PubMedCrossRef
29.
Putt ME, Reese PP, Volpp KG, Russell LB, Loewenstein G, Yan J, et al. The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: rationale, design and methodologies. Clin Trials. 2019;16(4):399–409.PubMedPubMedCentralCrossRef
30.
Barankay I, Reese PP, Putt ME, Russell LB, Loewenstein G, Pagnotti D, et al. Effect of patient financial incentives on statin adherence and lipid control: a randomized clinical trial. JAMA Netw Open. 2020;3(10):e2019429.PubMedPubMedCentralCrossRef
31.
Petry NM, Cengiz E, Wagner JA, Weyman K, Tichy E, Tamborlane WV. Testing for rewards: a pilot study to improve type 1 diabetes management in adolescents. Diabetes Care. 2015;38(10):1952–4.PubMedPubMedCentralCrossRef
32.
Raiff BR, Barrry VB, Ridenour TA, Jitnarin N. Internet-based incentives increase blood glucose testing with a non-adherent, diverse sample of teens with type 1 diabetes mellitus: a randomized controlled Trial. Transl Behav Med. 2016;6(2):179–88.PubMedPubMedCentralCrossRef
33.
Lansing AH, Stanger C, Budney A, Christiano AS, Casella SJ. Pilot study of a web-delivered multicomponent intervention for rural teens with poorly controlled type 1 diabetes. J Diabetes Res. 2016;2016:7485613.PubMedPubMedCentralCrossRef
34.
Stanger C, Lansing AH, Scherer E, Budney A, Christiano AS, Casella SJ. A web-delivered multicomponent intervention for adolescents with poorly controlled type 1 diabetes: a pilot randomized controlled trial. Ann Behav Med. 2018;52(12):1010–22.PubMedPubMedCentralCrossRef
35.
Sen AP, Sewell TB, Riley EB, Stearman B, Bellamy SL, Hu MF, et al. Financial incentives for home-based health monitoring: a randomized controlled trial. J Gen Intern Med. 2014;29(5):770–7.PubMedPubMedCentralCrossRef
36.
Dyal N, McAssey K, Agarwal G. Evaluation of a computerized self-management tool for children with type 1 diabetes: a pilot project. Can J Diabetes. 2017;41(2):124–8.PubMedCrossRef
37.
Malik FS, Senturia KD, Lind CD, Chalmers KD, Yi-Frazier JP, Shah SK, et al. Adolescent and parent perspectives on the acceptability of financial incentives to promote self-care in adolescents with type 1 diabetes. Pediatr Diabetes. 2020;21(3):533–51.PubMedPubMedCentralCrossRef
38.
• Nally LM, Wagner J, Sherr J, Tichy E, Weyman K, Ginley MK, et al. A pilot study of youth with type 1 diabetes initiating use of a hybrid closed-loop system while receiving a behavioral economics intervention. Endocr Pract. 2021;27(6):545–51 This pilot study tested financial incentives to promote optimal use of the 670G hybrid closed-loop system in adolescents with type 1 diabetes and the results reinforce the potential efficacy of using incentives for discrete and measurable diabetes-related tasks.PubMedCrossRef
39.
Kaushal T, Katz LEL, Joseph J, Marowitz M, Morales KH, Atkins D, et al. A text messaging intervention with financial incentive for adolescents with type 1 diabetes. J Diabetes Sci Technol. 2020;1932296820952786.
40.
Fernandes R, Chinn CC, Li D, Halliday T, Frankland T, Ozaki RR. Impact of financial incentives on health outcomes and costs of care among Medicaid beneficiaries with diabetes in Hawai’i. Hawaii J Med Public Health. 2019;78(1):19–25.PubMedPubMedCentral
41.
Ariely D, Loewenstein G, Prelec D. Tom Sawyer and the construction of value. J Econ Behav Organ. 2006;60:1–10.CrossRef
42.
Wong CA, Miller VA, Murphy K, Small D, Ford CA, Willi SM, et al. Effect of financial incentives on glucose monitoring adherence and glycemic control among adolescents and young adults with type 1 diabetes: a randomized clinical trial. JAMA Pediatr. 2017;171(12):1176–83.PubMedPubMedCentralCrossRef
43.
• Rouyard T, Leal J, Baskerville R, Velardo C, Salvi D, Gray A. Nudging people with Type 2 diabetes towards better self-management through personalized risk communication: a pilot randomized controlled trial in primary care. Endocrinol Diabetes Metab. 2018;1(3):e00022 This unique pilot study reports initial efficacy for using loss aversion in personal health communications to improve the dietary behaviors of adults with type 2 diabetes.PubMedPubMedCentralCrossRef
44.
• Belli HM, Chokshi SK, Hegde R, Troxel AB, Blecker S, Testa PA, et al. Implementation of a behavioral economics electronic health record (BE-EHR) module to reduce overtreatment of diabetes in older adults. J Gen Intern Med. 2020;35(11):3254–61 This pilot study reports promising results for an intervention that leveraged default bias to change physician practice in managing older adults with diabetes.PubMedPubMedCentralCrossRef
45.
Sallis A, Bunten A, Bonus A, James A, Chadborn T, Berry D. The effectiveness of an enhanced invitation letter on uptake of National Health Service Health Checks in primary care: a pragmatic quasi-randomised controlled trial. BMC Fam Pract. 2016;17:35.PubMedPubMedCentralCrossRef
46.
Rogers EA, Fine S, Handley MA, Davis H, Kass J, Schillinger D. Development and early implementation of the bigger picture, a youth-targeted public health literacy campaign to prevent type 2 diabetes. J Health Commun. 2014;19(Suppl 2):144–60.PubMedPubMedCentralCrossRef
47.
• Pansu P, Fointiat V, Lima L, Blatier C, Flore P, Vuillerme N. Changing behaviors: using norms to promote physical activity for type 2 diabetes patients. Eur Rev Appl Psychol. 2019;69:59–64 This study found preliminary efficacy for an intervention based on social norm messaging to promote physical activity in adults with type 2 diabetes.CrossRef
Metadata
Title
Applying Behavioral Economics Theories to Interventions for Persons with Diabetes
Authors
Susana R. Patton
Christopher C. Cushing
Amy Hughes Lansing
Publication date
01-05-2022
Publisher
Springer US
Published in
Current Diabetes Reports / Issue 5/2022
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-022-01460-5

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits